IL82401A0 - Dopamine beta hydroxy-lase inhibiting imidazole derivatives and pharmaceutical compositions containing them - Google Patents
Dopamine beta hydroxy-lase inhibiting imidazole derivatives and pharmaceutical compositions containing themInfo
- Publication number
- IL82401A0 IL82401A0 IL82401A IL8240187A IL82401A0 IL 82401 A0 IL82401 A0 IL 82401A0 IL 82401 A IL82401 A IL 82401A IL 8240187 A IL8240187 A IL 8240187A IL 82401 A0 IL82401 A0 IL 82401A0
- Authority
- IL
- Israel
- Prior art keywords
- lase
- inhibiting
- pharmaceutical compositions
- imidazole derivatives
- compositions containing
- Prior art date
Links
- 108010015720 Dopamine beta-Hydroxylase Proteins 0.000 title abstract 2
- 102100033156 Dopamine beta-hydroxylase Human genes 0.000 title abstract 2
- 150000002460 imidazoles Chemical class 0.000 title abstract 2
- 229940079865 intestinal antiinfectives imidazole derivative Drugs 0.000 title abstract 2
- 230000002401 inhibitory effect Effects 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 229940030600 antihypertensive agent Drugs 0.000 abstract 1
- 239000002220 antihypertensive agent Substances 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/84—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Fire-Extinguishing Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Processing Of Solid Wastes (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US86026386A | 1986-05-06 | 1986-05-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL82401A0 true IL82401A0 (en) | 1987-11-30 |
Family
ID=25332828
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL82401A IL82401A0 (en) | 1986-05-06 | 1987-05-01 | Dopamine beta hydroxy-lase inhibiting imidazole derivatives and pharmaceutical compositions containing them |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0244803B1 (da) |
| JP (1) | JP2581556B2 (da) |
| KR (1) | KR950013028B1 (da) |
| CN (1) | CN87103323A (da) |
| AT (2) | ATE113283T1 (da) |
| AU (1) | AU596410B2 (da) |
| CA (1) | CA1334199C (da) |
| DE (1) | DE3750685T2 (da) |
| DK (1) | DK229187A (da) |
| ES (1) | ES2065881T3 (da) |
| FI (1) | FI871981A7 (da) |
| HU (1) | HU198479B (da) |
| IL (1) | IL82401A0 (da) |
| NO (1) | NO871861L (da) |
| NZ (1) | NZ220184A (da) |
| PT (1) | PT84823B (da) |
| ZA (1) | ZA873176B (da) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4634711A (en) * | 1985-08-02 | 1987-01-06 | Smithkline Beckman Corporation | Pyridylalkyl imidazole-2-thiols |
| US4686231A (en) * | 1985-12-12 | 1987-08-11 | Smithkline Beckman Corporation | Inhibition of 5-lipoxygenase products |
| FI91754C (fi) * | 1986-12-02 | 1994-08-10 | Tanabe Seiyaku Co | Analogiamenetelmä lääkeaineena käyttökelpoisen imidatsolijohdannaisen valmistamiseksi |
| EP0277384A3 (en) * | 1986-12-24 | 1990-05-23 | Janssen Pharmaceutica N.V. | 1h-imidazole-5-carboxylic acid derivatives |
| EP0285356A3 (en) * | 1987-03-30 | 1989-05-31 | Smithkline Beecham Corporation | Dopamine-beta-hydroxylase inhibitors |
| US4839375A (en) * | 1987-07-28 | 1989-06-13 | Merrell Dow Pharmaceuticals Inc. | (Aryl or heteroaromatic methyl)-2,2'-bi-1H-imidazoles and their use as anti-hypertensive agents |
| HU202516B (en) * | 1987-10-02 | 1991-03-28 | Egyt Gyogyszervegyeszeti Gyar | Process for producing (2-thenyl)-thiourea derivatives and yield increasing agents comprising such compounds |
| CA2002246A1 (en) * | 1988-12-01 | 1990-06-01 | Lawrence I. Kruse | Dopamine-.beta.-hydroxylase inhibitors |
| CA2002247A1 (en) * | 1988-12-01 | 1990-06-01 | Lawrence I. Kruse | Dopamine-.beta.-hydroxylase inhibitors |
| EP0449445A3 (en) * | 1990-03-27 | 1993-08-25 | Pfizer Inc. | Preparation of beta-ketoesters useful in preparing quinolone antibiotics |
| US5635521A (en) * | 1991-09-23 | 1997-06-03 | Sandoz Ltd. | Imidazolylmethyl-pyridines |
| DE19627310A1 (de) * | 1996-06-27 | 1998-01-02 | Schering Ag | Imidazolderivate als Stickstoffmonoxid-Synthase-Inhibitoren |
| GB2393958A (en) * | 2002-10-11 | 2004-04-14 | Portela & Ca Sa | Peripherally-selective imidazole inhibitors of dopamine-beta-hydroxylase |
| US7538107B2 (en) | 2006-08-15 | 2009-05-26 | Wyeth | Oxazinan-2-one derivatives useful as PR modulators |
| US7649007B2 (en) | 2006-08-15 | 2010-01-19 | Wyeth Llc | Oxazolidine derivatives as PR modulators |
| US7618989B2 (en) | 2006-08-15 | 2009-11-17 | Wyeth | Tricyclic oxazolidone derivatives useful as PR modulators |
| US7652018B2 (en) | 2006-08-15 | 2010-01-26 | Wyeth Llc | Imidazolidin-2-one derivatives useful as PR modulators |
| WO2009097416A1 (en) * | 2008-01-29 | 2009-08-06 | Vanda Pharmaceuticals, Inc. | Imidazolylalkyl- pyridines as dbh inhibitors |
| CN103214421B (zh) * | 2012-12-11 | 2016-03-02 | 上海博康精细化工有限公司 | 2-巯基-1-甲基咪唑的工业化生产方法 |
| AU2022213938A1 (en) | 2021-01-26 | 2023-09-07 | Asieris Pharmaceuticals (Shanghai) Co., Ltd. | Pathway modulator, pharmaceutical composition having same, use thereof, and therapeutic method using same |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE312877C (da) * | ||||
| FR1509975A (fr) * | 1965-10-21 | 1968-01-19 | Geigy Ag J R | Dérivés de l'imidazole et leur préparation |
| FR2073427A1 (en) * | 1969-11-28 | 1971-10-01 | Sogeras | 4-methyl-5-ethyl-n-heterocyclic thiazoles - with antianoxic activity |
| DE2862340D1 (en) * | 1978-02-01 | 1983-11-24 | Wellcome Found | Imidazole derivatives and salts thereof, their synthesis, and pharmaceutical formulations thereof |
| GB2028317B (en) * | 1978-08-15 | 1982-11-10 | Pfizer Ltd | 2-(imidazol-1-ylmethyl)-pyridine and -quinoline thromboxane synthetase inhibitors |
| GR73560B (da) * | 1979-02-24 | 1984-03-15 | Pfizer | |
| DE3128277A1 (de) * | 1981-07-17 | 1983-02-03 | A. Nattermann & Cie GmbH, 5000 Köln | (omega)-(5-(1-imidazolylmethyl)-thien-2-y1)-alkancarbonsaeuren und deren derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate |
| DE3228266A1 (de) * | 1982-07-29 | 1984-02-02 | A. Nattermann & Cie GmbH, 5000 Köln | Imidazolylalkylthiophene, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate |
| DE3300795A1 (de) * | 1983-01-12 | 1984-07-12 | Bayer Ag, 5090 Leverkusen | Substituierte 4-imidazolyl-pyrazole, verfahren zu ihrer herstellung sowie diese enthaltende arzneimittel |
| PT78388B (en) * | 1983-04-12 | 1986-09-15 | Smithkline Beckman Corp | Dopamine-beta-hydroxylase inhibitors |
| US4532331A (en) * | 1983-04-12 | 1985-07-30 | Smithkline Beckman Corporation | 1-Benzyl-2-aminomethyl imidazole derivatives |
| US4634711A (en) * | 1985-08-02 | 1987-01-06 | Smithkline Beckman Corporation | Pyridylalkyl imidazole-2-thiols |
-
1987
- 1987-05-01 IL IL82401A patent/IL82401A0/xx not_active IP Right Cessation
- 1987-05-01 JP JP62106478A patent/JP2581556B2/ja not_active Expired - Fee Related
- 1987-05-04 ES ES87106440T patent/ES2065881T3/es not_active Expired - Lifetime
- 1987-05-04 EP EP87106440A patent/EP0244803B1/en not_active Expired - Lifetime
- 1987-05-04 NZ NZ220184A patent/NZ220184A/en unknown
- 1987-05-04 ZA ZA873176A patent/ZA873176B/xx unknown
- 1987-05-04 AT AT87106440T patent/ATE113283T1/de not_active IP Right Cessation
- 1987-05-04 PT PT84823A patent/PT84823B/pt not_active IP Right Cessation
- 1987-05-04 AU AU72463/87A patent/AU596410B2/en not_active Ceased
- 1987-05-04 DE DE3750685T patent/DE3750685T2/de not_active Expired - Fee Related
- 1987-05-05 CN CN198787103323A patent/CN87103323A/zh active Pending
- 1987-05-05 CA CA000536384A patent/CA1334199C/en not_active Expired - Fee Related
- 1987-05-05 HU HU872013A patent/HU198479B/hu not_active IP Right Cessation
- 1987-05-05 NO NO871861A patent/NO871861L/no unknown
- 1987-05-05 FI FI871981A patent/FI871981A7/fi not_active Application Discontinuation
- 1987-05-05 DK DK229187A patent/DK229187A/da not_active Application Discontinuation
- 1987-05-06 KR KR1019870004414A patent/KR950013028B1/ko not_active Expired - Fee Related
- 1987-10-12 AT AT0269087A patent/AT387967B/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| FI871981A0 (fi) | 1987-05-05 |
| EP0244803B1 (en) | 1994-10-26 |
| KR950013028B1 (ko) | 1995-10-24 |
| CA1334199C (en) | 1995-01-31 |
| PT84823B (pt) | 1989-12-29 |
| FI871981A7 (fi) | 1987-11-07 |
| HU198479B (en) | 1989-10-30 |
| ATE113283T1 (de) | 1994-11-15 |
| CN87103323A (zh) | 1988-02-03 |
| DK229187D0 (da) | 1987-05-05 |
| AU596410B2 (en) | 1990-05-03 |
| JPH01100160A (ja) | 1989-04-18 |
| DK229187A (da) | 1987-11-07 |
| DE3750685D1 (de) | 1994-12-01 |
| KR870011104A (ko) | 1987-12-21 |
| AU7246387A (en) | 1987-11-12 |
| EP0244803A3 (en) | 1991-01-16 |
| NO871861D0 (no) | 1987-05-05 |
| PT84823A (en) | 1987-06-01 |
| ES2065881T3 (es) | 1995-03-01 |
| JP2581556B2 (ja) | 1997-02-12 |
| AT387967B (de) | 1989-04-10 |
| ZA873176B (en) | 1987-10-28 |
| HUT44029A (en) | 1988-01-28 |
| NZ220184A (en) | 1990-04-26 |
| EP0244803A2 (en) | 1987-11-11 |
| DE3750685T2 (de) | 1995-03-02 |
| ATA269087A (de) | 1988-09-15 |
| NO871861L (no) | 1987-11-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL82401A0 (en) | Dopamine beta hydroxy-lase inhibiting imidazole derivatives and pharmaceutical compositions containing them | |
| IL97025A0 (en) | 17beta-substituted-4-aza-5alpha-androstan-3-one derivatives,their preparation and pharmaceutical compositions containing them | |
| AU2867992A (en) | Substituted heterocyclic derivatives useful as platelet aggregation inhibitors | |
| NO923265D0 (no) | Benzol(f)quinolinoner | |
| NZ216495A (en) | Fungicidal compositions containing benzopyran derivatives; certain of such compounds | |
| DE3170623D1 (en) | Guanidine derivatives and pharmaceutical compositions containing them | |
| NZ212658A (en) | Phenylnaphthyridine derivatives and pharmaceutical compositions | |
| HUT51288A (en) | Process for production of derivatives of 19-substituated progesteron and medical compositions containing them | |
| ZA872664B (en) | Six-membered heterocyclic derivatives of n'-substituted-n,n'-diacylhydrazines | |
| IL75638A0 (en) | Aryl derivatives of heterobicyclic compounds,their preparation and pharmaceutical compositions containing them | |
| NZ214697A (en) | B-methylene-2- and 3-furanethanamine and pharmaceutical compositions | |
| HUT50465A (en) | Process for producing amino-alkyl-substituted heterocyclic sulfur-compounds and pharmaceutical compositions containing them as active components | |
| ES8703866A1 (es) | Un procedimiento para preparar una amina alilica | |
| ATE38029T1 (de) | Benz-trisubstituierte 2-aminotetraline. | |
| HUT51289A (en) | Process for production of derivatives of 19-fluor or zyan-21-hydroxiprogesteron and medical compositions containing them | |
| CA1246075A (en) | AMINOALKOXYBENZOPYRANONES USED AS ANTIPSYCHOTIC AGENTS | |
| ES8400443A1 (es) | Mejoras introducidas en un procedimiento para la preparacion de hidroximidatos y tiolhidroximidatos heterobiciclicos y derivados ester carbamato de lso mismos. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RH | Patent void |